[1]Christian SM, Koehn D, Pillay R, et al. Parental decisions following prenatal diagnosis of sex chromosome aneuploidy: a trend over time. Prenat Diagn. 2000;20(1):37-40.
[2]Nielsen J, Wohlert M. Sex chromosome abnormalities found among 34,910 newborn children: Results from a 13-year incidence study in Arhus, Denmark. Birth Defects Orig Artic Ser.1990; 26: 209–223.
[3]Ramdaney A, Hoskovec J, Harkenrider J, et al. Clinical experience with sex chromosome aneuploidies detected by noninvasive prenatal testing (NIPT): Accuracy and patient decision-making. Prenat Diagn. 2018;38(11):841-848.
[4]Linden MG, Bender BG, Robinson A, et al. Genetic counseling for sex chromosome abnormalities[J]. Am J Med Genet. 2002; 110(1):3-10.
[5]Ottesen AM, Aksglaede L, Garn I, et al. Increased number of sex chromosomes affects height in a nonlinear fashion: a study of 305 patients with sex chromosome aneuploidy. Am J Med Genet A. 2010;152A(5):1206–1212.
[6]So PL, Cheng KYY, Cheuk KY, et al. Parental decisions following prenatal diagnosis of sex chromosome aneuploidy in Hong Kong. J Obstet Gynaecol Res. 2017;43(12):1821-1829.
[7]Hu H, Wang L, Wu J, et al. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies. Hum Genomics. 2019;13(1):14.
[8]Chitty LS, Lo YM. Noninvasive Prenatal Screening for Genetic Diseases Using Massively Parallel Sequencing of Maternal Plasma DNA. Cold Spring Harb Perspect Med. 2015;5(9):a023085.
[9]Ronzoni L, Silibello G, Quagliarini D, et al. A comment on "clinical experience with sex chromosome aneuploidies detected by noninvasive prenatal testing (NIPT): Accuracy and patient decision-making". Prenat Diagn. 2018;38(13):1129-1130.
[10]Gregg AR, Skotko BG, Benkendorf JL et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: A position statement of the American College of Medical Genetics and Genomics. Genet Med. 2016;18:1056–1065.
[11]Kalafat E, Seval MM, Turgay B, et al. Non-invasive prenatal testing for sex chromosome abnormalities: a source of confusion. BMJ Case Rep. 2015;18(3): 62.
[12]Xu Y, Chen L, Liu Y, et al. Screening, prenatal diagnosis, and prenatal decision for sex chromosome aneuploidy. Expert Rev Mol Diagn. 2019;19(6):537-542.
[13]Chen Y, Yu Q, Mao X, et al. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 42,910 single pregnancies with different clinical features. Hum Genomics. 2019;13(1):60.
[14]Kim SY, Lee SM, Jun JK, et al. Prospective observations study protocol to investigate cost-effectiveness of various prenatal test strategies after the introduction of noninvasive prenatal testing. BMC Pregnancy Childbirth. 2018;18(1):307.
[15]Jones KJ, Wang E, Bogard P, et al. Targeted cell-free DNA analysis with microarray quantitation for assessment of fetal sex and sex chromosome aneuploidy risk. Ultrasound Obstet Gynecol. 2018;51(2):275–276.
[16]Taneja PA, Snyder HL, De Feo E, et al. Noninvasive prenatal testing in the general obstetric population: clinical performance and counseling considerations in over 85 000 cases. Prenat Diagn. 2016;36(3):237–243.
[17]Gekas J, Langlois S, Ravitsky V, et al. Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues. Appl Clin Genet. 2016;9:15–26.
[18]Zhang B, Lu BY, Yu B, et al. Noninvasive prenatal screening for fetal common sex chromosome aneuploidies from maternal blood. J Int Med Res. 2017;45(2):621–630.
[19]Nicolaides KH, Musci TJ, Struble CA, et al. Assessment of fetal sex chromosome aneuploidy using directed cell-free DNA analysis. Fetal Diagn Ther. 2014;35(1):1-6.
[20]Russell LM, Strike P, Browne CE, et al. X chromosome loss and aging. Cytogenet Genome Res. 2007;116(3):181-185.
[21]García-Acero M, Moreno-Niño O, Suárez-Obando F, et al. Disorders of sex development: Genetic characterization of a patient cohort published online ahead of print. Mol Med Rep. 2019;21(1):97–106.
[22]Berglund A, Viuff MH, Skakkebæk A, et al. Changes in the cohort composition of turner syndrome and severe non-diagnosis of Klinefelter, 47,XXX and 47,XYY syndrome: a nationwide cohort study. Orphanet J Rare Dis. 2019;14(1):16.
[23]Pieters JJ, Kooper AJ, van Kessel AG, et al. Incidental prenatal diagnosis of sex chromosome aneuploidies:Health, behavior, and fertility. ISRN Obstet Gynecol. 2011; 20:106.
[24]Gil MM, Quezada MS, Revello R, et al. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: Updated meta-analysis. Ultrasound Obstet Gynecol.2015; 45: 249–266.
[25]Van Rijn S. A review of neurocognitive functioning and risk for psychopathology in sex chromosome trisomy (47,XXY, 47,XXX, 47, XYY). Curr Opin Psychiatry. 2019;32(2):79–84.
[26]Nishiyama M, Sekizawa A, Ogawa K,et al. Factors affecting parental decisions to terminate pregnancy in the presence of chromosome abnormalities: a Japanese multicenter study. Prenat Diagn. 2016;36(12):1121-1126.
[27]Liao C, Li DZ. Pregnancy outcome following prenatal diagnosis of sex chromosome abnormalities in Mainland China. Prenat Diagn 2008; 28:443–444.
[28]Suzumori N, Kumagai K, Goto S, et al. Parental decisions following prenatal diagnosis of chromosomal abnormalities: implications for genetic counseling practice in Japan. J Genet Couns. 2015;24(1):117-121.
[29]Kim YJ, Park SY, Han JH, et al. Parental decisions of prenatally detected sex chromosome abnormality. J Korean Med Sci. 2002;17(1):53–57.
[30]Snyder HL, Curnow KJ, Bhatt S, et al. Follow-up of multiple aneuploidies and single monosomies detected by noninvasive prenatal testing: implications for management and counseling. Prenat Diagn. 2016;36(3):203–209.
[31]Wilson AC, King J, Bishop DVM, et al. Autism and social anxiety in children with sex chromosome trisomies: an observational study. Wellcome Open Res. 2019;4(6):32.
[32]Chai H, DiAdamo A, Grommisch B, et al. A Retrospective Analysis of 10-Year Data Assessed the Diagnostic Accuracy and Efficacy of Cytogenomic Abnormalities in Current Prenatal and Pediatric Settings. Front Genet. 2019;10(3):1162.